Former President Donald Trump has ended a protracted search for a permanent leader of the US Centers for Disease Control and Prevention (CDC) by nominating Dr Erica Schwartz, a rear admiral with a formidable record in public health and military service, to direct the troubled agency.
Trump announced the decision on his Truth Social platform, declaring it an “Honour” to nominate the “incredibly talented” Dr Schwartz, whom he described as a “STAR!” The appointment, which requires confirmation by the US Senate, places a figure with a unique blend of medical, legal, and operational experience at the helm of an organisation that has faced significant political and internal upheaval.
Dr Schwartz brings more than two decades of uniformed service to the role, having held positions across the US Navy, the US Public Health Service Commissioned Corps, and the US Coast Guard. Her most prominent political appointment was serving as Deputy Surgeon General from 2019 to 2021 during Trump’s first term. Her qualifications are notably broad: she holds a bachelor’s degree in biomedical engineering and a medical degree from Brown University, a master’s in public health from the Uniformed Services University of the Health Sciences, and a law degree from the University of Maryland.
Her background is not purely academic. Within the Coast Guard, Dr Schwartz developed policy on pandemic influenza and other viral disease outbreaks, giving her direct experience in the kind of large-scale public health planning central to the CDC’s mission. This practical expertise in outbreak response will be immediately relevant for an agency striving to restore its scientific authority.
Agency instability and political pressure
Dr Schwartz is nominated to lead an institution marked by recent turbulence. The CDC’s last Senate-confirmed director, Susan Monarez, served for less than a month in 2025 before being fired after clashing with Health and Human Services Secretary Robert F. Kennedy Jr. over what has been described as his “anti-vaccine agenda.”
Following her departure, Dr Jay Bhattacharya served as acting director. However, his designation expired last month under the federal Vacancies Act, which generally restricts acting officials to 210 days in posts requiring Senate confirmation. During a staff meeting in March, Dr Bhattacharya himself reportedly pointed to a series of difficulties the agency faced, including repeated layoffs and declining morale.
The challenges are both internal and external. Since returning to office in January, Secretary Kennedy and his team have taken public and private steps aimed at slowing vaccine research and guidance, a stance that has caused alarm among public health advocates. The political pressure on the CDC’s leadership is intense and explicit.
The health policy group Protect Our Care has already called on Dr Schwartz to promise she will stand up for the safety and effectiveness of vaccination. Kayla Hancock, director of the group’s public health project, stated that the next CDC director “must be free and independent to encourage as many Americans as possible to protect themselves from preventable diseases without first getting permission from the anti-vaxxer-in-chief.”
Trauma and a broader leadership overhaul
Beyond political battles, the CDC has also endured physical trauma. In August 2025, a gunman opened fire outside the agency’s Atlanta campus, resulting in the death of a police officer. The shooter, identified as Patrick Joseph White, reportedly blamed the COVID-19 vaccine for his depression and suicidal thoughts. The incident left at least four CDC buildings damaged, with over 180 shots fired and approximately 150 windows broken.
In his announcement, President Trump framed Dr Schwartz’s nomination as part of a wider effort to restore the agency’s rigour, stating his nominees possess the “knowledge, experience, and TOP degrees to restore the GOLD STANDARD OF SCIENCE at the CDC.” Alongside Dr Schwartz, he nominated Sean Slovenski as CDC deputy director and chief operating officer, Dr Jennifer Shuford as deputy director and chief medical officer, and Dr Sara Brenner as senior counselor for public health to Secretary Kennedy.
Dr Schwartz, if confirmed, would follow a line of CDC directors who have navigated the politically charged landscape of the Trump administrations. Previous directors include Robert R. Redfield, who served from 2018 to 2021, and Brenda Fitzgerald, who served briefly in 2017-2018. Trump had previously nominated former Congressman Dave Weldon for the role in November 2024, but that nomination was later withdrawn, leading to the lengthy search now concluded.